| 1 | Pharmacogenetics: ethnicity, treatment and health in Latin American populations | Coautor: Lopez-Lopez, Marisol, Sosa-Macias, Martha, Fricke-Galindo, Ingrid, Farinas, Humberto, et al. | 2023 | Pharmacogenomics | WoS-id: 001041397500001
Scopus-id: 2-s2.0-85168222657
| 0 | 2 |
| 2 | The role of alcohol intake in the pharmacogenetics of treatment with clozapine | Coautor: López-López M., Monroy-Jaramillo N., Martínez-Magaña J.J., Pérez-Aldana B.E., et al. | 2022 | Pharmacogenomics | WoS-id: 000771718100001
Scopus-id: 2-s2.0-85128396262
| 1 | 2 |
| 3 | Clozapine Long-Term Treatment Might Reduce Epigenetic Age Through Hypomethylation of Longevity Regulatory Pathways Genes | Coautor: López-López M., Pérez-Aldana B.E., Martínez-Magaña J.J., Mayén-Lobo Y.G., et al. | 2022 | Frontiers in Psychiatry | WoS-id: 000806123100001
Scopus-id: 2-s2.0-85131601297
| 0 | 1 |
| 4 | Impact of COMT, PRODH and DISC1 Genetic Variants on Cognitive Performance of Patients with Schizophrenia | Coautor: López-López M., Fricke-Galindo I., Pérez-Aldana B.E., Macías-Kauffer L.R., et al. | 2022 | Archives Of Medical Research | WoS-id: 000880002700006
Scopus-id: 2-s2.0-85127327227
| 1 | 2 |
| 5 | Alcohol intake potentiates clozapine adverse effects associated to CYP1A2*1C in patients with refractory psychosis | Coautor: López-López M., Ortega-Vázquez A., Mayen-Lobo Y.G., Dávila-Ortiz de Montellano D.J., et al. | 2021 | DRUG DEVELOPMENT RESEARCH | WoS-id: 000599520400001
Scopus-id: 2-s2.0-85097666570
| 5 | 5 |
| 6 | Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital | Coautor: Lopez-Lopez, Marisol, Fricke-Galindo, Ingrid, Jung-Cook, Helgi, Martinez-Juarez, Iris E., et al. | 2021 | Pharmacogenomics | WoS-id: 000703916100001
Scopus-id: 2-s2.0-85117349986
| 0 | 1 |
| 7 | Integrative genomic?epigenomic analysis of clozapine-treated patients with refractory psychosis | Coautor: López-López M., Mayén-Lobo Y.G., Martínez-Magaña J.J., Pérez-Aldana B.E., et al. | 2021 | Pharmaceuticals | Scopus-id: 2-s2.0-85100802082
| 0 | 7 |
| 8 | Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans | Coautor: López-López M., Rodrigues-Soares F., Peñas-Lledó E.M., Tarazona-Santos E., et al. | 2020 | CLIN PHARMACOL THER | WoS-id: 000512979000047
Scopus-id: 2-s2.0-85073919824
| 22 | 28 |
| 9 | High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations | Coautor: Lopez-Lopez, Marisol, Sarmiento, Alba P., Dorado, Pedro, Borbon, Angelica, et al. | 2020 | Pharmacogenomics | WoS-id: 000584494200001
Scopus-id: 2-s2.0-85096947039
| 0 | 1 |
| 10 | STRA6 Polymorphisms Are Associated With EGFR Mutations in Locally-Advanced and Metastatic Non-Small Cell Lung Cancer Patients | Coautor: López-López M., Muñiz-Hernández S., Velázquez-Fernández J.B., Díaz-Chávez J., et al. | 2020 | Frontiers in Oncology | WoS-id: 000596557100001
Scopus-id: 2-s2.0-85097414242
| 6 | 8 |
| 11 | Carbamazepine adverse drug reactions | Coautor: Lopez-Lopez, Marisol, Fricke-Galindo, Ingrid, LLerena, Adrian, Jung-Cook, Helgi | 2018 | EXPERT REVIEW OF CLINICAL PHARMACOLOGY | WoS-id: 000440067200006
Scopus-id: 2-s2.0-85051315295
| 42 | 58 |
| 12 | Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms | Coautor: López-López M., Favela-Mendoza A.F., Rangel-Villalobos H., Fricke-Galindo I., et al. | 2018 | MOLECULAR BIOLOGY REPORTS | WoS-id: 000452543200092
Scopus-id: 2-s2.0-85055248430
| 8 | 9 |
| 13 | ¿Qué sabe usted acerca de...Genómica? | 1ᵉʳ autor: López-López M., López Gutiérrez A.U., Del Rosario Sainz Espuñes T., Rosales Torres A.M. | 2005 | Revista Mexicana de Ciencias Farmaceuticas | Scopus-id: 2-s2.0-18344388990
| 0 | 0 |
ORCID's 